羟基氟他胺未必总是一种纯粹的抗雄激素药物。 - Suppr

Suppr

超能文献

Hydroxyflutamide may not always be a pure antiandrogen.

作者信息

Yeh S, Miyamoto H, Chang C

出版信息

Lancet. 1997 Mar 22;349(9055):852-3. doi: 10.1016/S0140-6736(05)61756-4.

DOI:10.1016/S0140-6736(05)61756-4

PMID:9121269

Abstract

摘要

相似文献

Hydroxyflutamide may not always be a pure antiandrogen.

Lancet. 1997 Mar 22;349(9055):852-3. doi: 10.1016/S0140-6736(05)61756-4.

Differential induction of androgen receptor transactivation by different androgen receptor coactivators in human prostate cancer DU145 cells.

Endocrine. 1999 Oct;11(2):195-202. doi: 10.1385/endo:11:2:195.

From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells.

Proc Natl Acad Sci U S A. 1999 May 11;96(10):5458-63. doi: 10.1073/pnas.96.10.5458.

Therapeutic options in patients with hormone-refractory prostate cancer.

Am J Med. 1996 Feb;100(2):243-4. doi: 10.1016/s0002-9343(97)89468-5.

Combination of resveratrol and antiandrogen flutamide has synergistic effect on androgen receptor inhibition in prostate cancer cells.

Anticancer Res. 2011 Oct;31(10):3323-30.

Suppression of mutant androgen receptors by flutamide.

Int J Urol. 2009 May;16(5):516-21. doi: 10.1111/j.1442-2042.2009.02284.x. Epub 2009 Apr 6.

Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells.

Cancer Res. 2002 Nov 1;62(21):6039-44.

The mutated androgen receptor and its implications for the treatment of metastatic carcinoma of the prostate.

Pharmacotherapy. 1996 May-Jun;16(3):376-81.

Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer.

J Biol Chem. 2004 Aug 6;279(32):33438-46. doi: 10.1074/jbc.M401781200. Epub 2004 May 27.

A novel steroidal antiandrogen targeting wild type and mutant androgen receptors.

Biochem Pharmacol. 2011 Dec 1;82(11):1651-62. doi: 10.1016/j.bcp.2011.08.020. Epub 2011 Sep 1.

引用本文的文献

ARe we there yet? Understanding androgen receptor signaling in breast cancer.

NPJ Breast Cancer. 2020 Sep 25;6:47. doi: 10.1038/s41523-020-00190-9. eCollection 2020.

Human kallikrein 2 (KLK2) promotes prostate cancer cell growth via function as a modulator to promote the ARA70-enhanced androgen receptor transactivation.

Tumour Biol. 2014 Mar;35(3):1881-90. doi: 10.1007/s13277-013-1253-6.

The role of intracrine androgen metabolism, androgen receptor and apoptosis in the survival and recurrence of prostate cancer during androgen deprivation therapy.

Curr Drug Targets. 2013 Apr;14(4):420-40. doi: 10.2174/1389450111314040004.

Androgen receptor influences on body defense system via modulation of innate and adaptive immune systems: lessons from conditional AR knockout mice.

Am J Pathol. 2012 Nov;181(5):1504-12. doi: 10.1016/j.ajpath.2012.07.008. Epub 2012 Sep 4.

Expression and function of nuclear receptor co-activator 4: evidence of a potential role independent of co-activator activity.

Cell Mol Life Sci. 2012 Dec;69(23):3895-909. doi: 10.1007/s00018-012-1000-y. Epub 2012 May 5.

Cryptotanshinone suppresses androgen receptor-mediated growth in androgen dependent and castration resistant prostate cancer cells.

Cancer Lett. 2012 Mar;316(1):11-22. doi: 10.1016/j.canlet.2011.10.006. Epub 2011 Oct 10.

Monocyte/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-alpha expression.

J Clin Invest. 2009 Dec;119(12):3739-51. doi: 10.1172/JCI39335. Epub 2009 Nov 9.

Tissue prostate-specific antigen facilitates refractory prostate tumor progression via enhancing ARA70-regulated androgen receptor transactivation.

Cancer Res. 2008 Sep 1;68(17):7110-9. doi: 10.1158/0008-5472.CAN-07-6507.

Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma.

Gastroenterology. 2008 Sep;135(3):947-55, 955.e1-5. doi: 10.1053/j.gastro.2008.05.046. Epub 2008 May 22.

Inactivation of androgen receptor coregulator ARA55 inhibits androgen receptor activity and agonist effect of antiandrogens in prostate cancer cells.

Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5124-9. doi: 10.1073/pnas.0530097100. Epub 2003 Apr 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验